AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Declaration of Voting Results & Voting Rights Announcements Dec 12, 2023

5163_dva_2023-12-12_e94bdde1-eb45-4fb6-bb91-8552284cde59.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5548W

Intl. Biotechnology Trust PLC

12 December 2023

Annual General Meeting

International Biotechnology Trust plc (the "Company") announces that a poll was held on each of the resolutions proposed at the Annual General Meeting on 12 December 2023. The results of the poll are as follows:

Resolution Votes for (including discretionary votes) % Votes against % Withheld Total Votes Cast (excludes Votes Withheld)
1 To receive the Annual Report & Accounts 13,176,707 99.59% 54,014 0.41% 29,079 13,230,721
2 To approve Directors' Remuneration report 13,140,395 99.57% 57,300 0.43% 52,105 13,197,695
3 To approve Directors' Remuneration Policy 13,124,663 99.45% 73,076 0.55% 52,061 13,197,739
4 To approve the Company's dividend policy 13,221,854 99.96% 5,285 0.04% 32,661 13,227,139
5 To elect

Ms Gillian Elcock
13,183,660 99.81% 24,975 0.19% 41,165 13,208,635
6 To re-elect

Miss Kate Cornish-Bowden
13,186,241 99.81% 24,488 0.19% 39,071 13,210,729
7 To re-elect Mrs Caroline Gulliver 13,183,999 99.79% 28,180 0.21% 37,621 13,212,179
8 To re-elect Mr Patrick Magee 13,183,935 99.87% 17,526 0.13% 48,339 13,201,461
9 To re-elect Professor Patrick Maxwell 13,194,677 99.87% 17,502 0.13% 37,621 13,212,179
10 To re-appoint PricewaterhouseCoopers LLP as auditor 13,163,331 99.66% 44,749 0.34% 41,720 13,208,080
11 To authorise Directors' determination of the auditor's remuneration 13,205,377 99.86% 18,705 0.14% 35,718 13,224,082
12 To approve continuation of the Company 13,238,333 99.94% 7,585 0.06% 3,882 13,245,918
13 To renew the authority to allot shares 13,198,156 99.87% 16,797 0.13% 34,847 13,214,953
14 To renew the authority to allot additional shares 13,190,925 99.84% 20,952 0.16% 37,923 13,211,877
15* To approve the disapplication of pre-emption rights 13,149,544 99.53% 61,623 0.47% 38,633 13,211,167
16* To approve the disapplication of pre-emption rights for allotments of additional shares 12,825,508 96.87% 414,004 3.13% 10,288 13,239,512
17* To renew the authority to purchase own shares 13,211,282 99.89% 14,275 0.11% 34,243 13,225,557
18* To approve that a general meeting, other than an annual general meeting, may be called on not less than 14 clear days' notice 13,156,468 99.57% 57,054 0.43% 36,278 13,213,522

*Resolutions 15 to 18 were passed as special resolutions.

Shareholders are entitled to one vote per share. Votes withheld are not a vote in law and are therefore not counted in the calculation of the percentages of the votes cast for and against a resolution. Where shareholders appointed the Chairman as their proxy with discretion as to voting, their votes were cast in favour of the resolutions and their shares have been included in the "votes for" column.

The total issued share capital consists of 41,383,817 ordinary shares of £0.25 each, which includes 2,500,210 ordinary shares held in treasury. Treasury shares do not carry voting rights, therefore the total number voting rights in the Company is 38,883,607.

In accordance with LR 9.6.2, a copy of the resolutions passed, other than resolutions concerning ordinary business, at today's AGM will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFFIFAEEDSEEE

Talk to a Data Expert

Have a question? We'll get back to you promptly.